ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 273 out of 939

$478K Total Retail Price of All Prescriptions

Rank: 265 out of 939

342 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 342 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

44% of this provider’s 342 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 5,051 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 459 176 S3 1 1
SIMVASTATIN 333 196 2 2
AZITHROMYCIN 222 84 3 32
POTASSIUM CHLORIDE 212 124 4 9
LISINOPRIL 208 152 5 3
FUROSEMIDE 199 123 6 7
PROMETHAZINE HCL 197 80 R 7 68
AMLODIPINE BESYLATE 191 96 8 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 82 9 23
WARFARIN SODIUM 175 133 10 17
TAMSULOSIN HCL 170 114 11 27
CEFTRIAXONE 166 82 12 197
GLIMEPIRIDE 165 81 13 37
METFORMIN HCL 164 97 14 8
MELOXICAM 152 70 15 14
LEVOTHYROXINE SODIUM 149 96 16 4
ATENOLOL 139 86 17 19
OMEPRAZOLE 135 69 18 5
CYCLOBENZAPRINE HCL 133 28 R 19 36
METOPROLOL TARTRATE 130 68 20 10
ESCITALOPRAM OXALATE 129 67 21 61
CLONIDINE HCL 120 60 22 39
GABAPENTIN 115 48 23 11
QUETIAPINE FUMARATE 113 75 24 69
TRAMADOL HCL 106 52 25 16
ZOLPIDEM TARTRATE 100 36 26 20
CIPROFLOXACIN HCL 99 54 27 54
METHYLPREDNISOLONE 99 37 27 118
NITROFURANTOIN MONO-MACRO 96 58 29 180
TRAZODONE HCL 94 31 30 26
NEXIUM 88 53 31 18
LYRICA 79 0 32 63
DEXAMETHASONE SODIUM PHOSPHATE 79 23 32 305
ALLOPURINOL 75 47 34 31
KLOR-CON M20 67 25 35 90
PREDNISONE 65 39 36 42
NITROGLYCERIN PATCH 65 49 36 279
DIGOXIN 65 40 36 45
SERTRALINE HCL 64 35 39 24
METOPROLOL SUCCINATE 63 33 40 21
TRIAMCINOLONE ACETONIDE 62 22 41 150
DONEPEZIL HCL 61 61 42 30
NASONEX 57 35 43 247
NAMENDA 56 56 44 49
CYMBALTA 55 0 45 44
FENTANYL 55 46 S2 45 104
SEROQUEL 55 39 45 139
PENTOXIFYLLINE 54 32 48 284
LEXAPRO 52 26 49 201
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 20 50 64
ENDOCET 51 0 S2 50 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.